Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
48.78
+0.86 (1.79%)
At close: Mar 9, 2026, 4:00 PM EDT
49.75
+0.97 (1.99%)
After-hours: Mar 9, 2026, 5:36 PM EDT

Company Description

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific.

It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal’s health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers.

In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers.

Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock’s diets and maintain optimal balance of trace elements in animals.

Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries.

It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors.

The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003.

Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Phibro Animal Health Corporation
Phibro Animal Health logo
Country United States
Founded 1946
IPO Date Apr 11, 2014
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 2,475
CEO Jack Bendheim

Contact Details

Address:
Glenpointe Centre East, 3rd Floor
Teaneck, New Jersey 07666-6712
United States
Phone 201 329 7300
Website pahc.com

Stock Details

Ticker Symbol PAHC
Exchange NASDAQ
Stock Type Common Stock
Share Class Class A Shares
Fiscal Year July - June
Reporting Currency USD
CIK Code 0001069899
CUSIP Number 71742Q106
ISIN Number US71742Q1067
Employer ID 13-1840497
SIC Code 2834

Key Executives

Name Position
Jack Clifford Bendheim Chairman, President and Chief Executive Officer
Glenn C. David Chief Financial Officer
Larry L. Miller Chief Operating Officer
Judith A. Weinstein Senior Vice President, General Counsel and Corporate Secretary
Daniel M. Bendheim J.D. Executive Vice President of Corporate Strategy and Director
Jonathan Bendheim Executive Vice President of Global Technology and People and Director
Lisa A. Escudero Senior Vice President of Human Resources
Ramon Fuenmayor President South America Region
Samson Li President of Asia Pacific Region
Todd Armstrong President of North American Region

Latest SEC Filings

Date Type Title
Feb 11, 2026 144 Filing
Feb 11, 2026 SCHEDULE 13G Filing
Feb 4, 2026 8-K Current Report
Feb 4, 2026 10-Q Quarterly Report
Feb 3, 2026 8-K Current Report
Dec 18, 2025 8-K Current Report
Dec 15, 2025 SCHEDULE 13D/A Filing
Dec 4, 2025 144 Filing
Nov 5, 2025 8-K Current Report
Nov 5, 2025 10-Q Quarterly Report